Penn Med Antimicrobial Stewardship

Quick links

COVID-19 treatment guidelines

Antimicrobial Stewardship Schedule: schedule of which pharmacist(s) and attending physicians are rotating on a given week at HUP

Drug shortages
Minor ceftazidime
Critical ceftazidime-avibactam1, primaquine, pentamidine, doxycycline IV, rifampin IV, tobramycin powder
Unavailable cefotaxime, amphotericin B (deoxycholate only)

1Ceftazidime-avibactam is unavailable due to a temporary shortage. We have a critically short supply. Providers should use alternative medications such as meropenem-vaborbactam when appropriate. Consult infectious diseases for additional advice.

Antimicrobial Stewardship Policy and Mission

The prevalence of antimicrobial resistance is increasing at an alarming rate, placing critical importance on the preservation of available antimicrobial agents. Antimicrobial stewardship is a practice aimed at monitoring and guiding antimicrobial use in healthcare settings using evidence-based practices. It is known that approximately 50% of inpatient antimicrobial use is inappropriate, and there is a clear association between use of antimicrobials and development of resistance. Numerous studies and national guidelines have supported stewardship as an integral strategy to reduce emergence of antimicrobial resistance, improve patient outcomes, and decrease healthcare costs.rapidly change based on new information.

The goals of the antimicrobial stewardship team are to:

  • Provide support to healthcare workers.
  • Decrease inappropriate antimicrobial use.
  • Optimize selection, dose, and duration of antimicrobial therapy.
  • Streamline costs associated with antimicrobial use.
  • Decrease spread and emergence of antimicrobial resistance.
  • Improve patient outcomes.

Antimicrobial stewardship policy at the Hospital of the University of Pennyslvania